Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Adicet Bio, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 49 | 56 | +7 |
| Shares | 6.41M | 6.11M | −300.6K (−4.7%) |
| Value | $43.7M | $52.8M | +$9.13M (+20.9%) |
New holders (13)
Institutions that held Adicet Bio, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 195,514 | $1.69M | 0.01% |
| Bridgeway Capital Management, LLC | 85,959 | $742.7K | 0.01% |
| Marshall Wace, LLP | 79,488 | $686.8K | 0.00% |
| Quadrature Capital Ltd | 36,193 | $312.7K | 0.00% |
| Verdad Advisers, LP | 25,200 | $217.7K | 0.21% |
| Susquehanna International Group, LLP | 20,650 | $178.4K | 0.00% |
| Prelude Capital Management, LLC | 18,550 | $160.3K | 0.01% |
| Squarepoint Ops LLC | 15,254 | $131.8K | 0.00% |
| Axq Capital, LP | 10,991 | $95.0K | 0.01% |
| Jump Financial, LLC | 10,942 | $94.5K | 0.00% |
| SRS Capital Advisors, Inc. | 6,000 | $51.8K | 0.00% |
| FMR LLC | 6 | $52 | 0.00% |
| TD Waterhouse Canada Inc. | 3 | $26 | 0.00% |
Sold out (6)
Institutions that held Adicet Bio, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Woodline Partners LP | 313,124 | $2.13M |
| Prosight Management, LP | 250,244 | $1.70M |
| ADAR1 Capital Management, LLC | 53,827 | $366.6K |
| Barclays PLC | 25,000 | $170.3K |
| GWM Advisors LLC | 3,854 | $26.2K |
| FNY Investment Advisers, LLC | 3,200 | $21.0K |